In May 2017, ASD acquired an inventory management system specialized for retina practices, according to a Dec. 13 news release from the Justice Department. Through November 2023, ASD offered the system at no cost to customers who entered agreements that required them to purchase a percentage of their specialty drugs from ASD.
ASD required customers who did not enter the agreements to pay a monthly fee for access. Additionally, following its acquisition of the system, ASD discontinued access to the system for non-ASD retina practices that had used the system prior to the acquisition, including those who offered to pay a monthly fee.
Carrollton, Texas-based ASD Specialty Healthcare distributes medical and pharmaceutical products, including ophthalmological injections that treat neovascular age-related macular degeneration.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.